Abstract 797: Integrating hematoxylin & eosin histology with multiplexed imaging mass cytometry for spatial proteomic profiling of antibody-drug conjugate targeted biomarkers. | Synapse
April 5, 2026
Abstract 797: Integrating hematoxylin & eosin histology with multiplexed imaging mass cytometry for spatial proteomic profiling of antibody-drug conjugate targeted biomarkers.
Key Points
This work aims to enhance histopathological insights through the integration of H&E staining with imaging mass cytometry to identify ADC-related biomarkers.
Developed a workflow combining H&E-stained sections with IMC antibody panels targeting ADC biomarkers.
Selected regions of interest based on histological features for IMC acquisition and analysis.
Performed computational analysis for cell phenotyping and spatial mapping of biomarkers.
Achieved high registration accuracy when aligning H&E images with IMC segmentation maps across various tissue types.
Demonstrated quantitative capability to detect and enumerate cells expressing ADC targets like HER2 and EGFR.
Uncovered spatial patterns of biomarker distribution that correlate with histopathological features.
Abstract
Abstract Hematoxylin and Eosin (H Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 797.